{"resourceType": "Evidence", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/comparative-evidence"], "versionId": "62", "lastUpdated": "2025-03-15T18:13:51.413Z"}, "identifier": [{"type": {"text": "FEvIR Object Identifier", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "ACSN", "display": "Accession ID"}]}, "system": "urn:ietf:rfc:3986", "value": "https://fevir.net/FOI/236546", "assigner": {"display": "Computable Publishing LLC"}}, {"type": {"text": "outcomeId"}, "system": "https://app.magicapp.org/#/guidelines", "value": "313878"}, {"type": {"text": "picoId"}, "system": "https://app.magicapp.org/#/guidelines", "value": "85789"}, {"type": {"text": "sectionId"}, "system": "https://app.magicapp.org/#/guidelines", "value": "73212"}], "name": "Nonfatal_myocardial_infarction_from_MAGICapp_313878", "title": "MAGIC-derived Evidence: Nonfatal myocardial infarction with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "status": "active", "author": [{"name": "Computable Publishing\u00ae: MAGIC-to-FEvIR Converter"}], "useContext": [{"code": {"system": "https://fevir.net/resources/CodeSystem/179423", "code": "evidence-communication", "display": "Evidence Communication"}, "valueCodeableConcept": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "ComparativeEvidence", "display": "ComparativeEvidence"}]}}], "variableDefinition": [{"description": "Adults with type 2 diabetes with moderate CV risk", "variableRole": "population", "observed": {"type": "Group", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-population-group-85390-85789", "assigner": {"display": "Computable Publishing LLC"}}, "display": "Adults with type 2 diabetes and established CVD (but no CKD)", "reference": "Group/236533"}}, {"description": "GroupAssignment: GLP-1 RA vs. Standard care", "variableRole": "exposure", "comparatorCategory": "Standard care", "observed": {"type": "EvidenceVariable", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-group-assignment-85390-85789", "assigner": {"display": "Computable Publishing LLC"}}, "display": "GroupAssignment: GLP-1 RA vs. Standard care", "reference": "EvidenceVariable/236536"}}, {"description": "Nonfatal myocardial infarction", "variableRole": "outcome", "observed": {"type": "EvidenceVariable", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-313878", "assigner": {"display": "Computable Publishing LLC"}}, "display": "Nonfatal myocardial infarction", "reference": "EvidenceVariable/236545"}}], "synthesisType": {"text": "SYSTEMATIC_REVIEW"}, "studyDesign": [{"coding": [{"system": "http://hl7.org/fhir/study-design", "code": "SEVCO:01003", "display": "randomized assignment"}]}], "statistic": [{"description": "Risk Difference -0.8% (CI95 -1.5% to -0.1%)", "statisticType": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/statistic-type", "version": "5.0.0-cibuild", "code": "0000424", "display": "Risk Difference"}]}, "quantity": {"value": -0.008}, "sampleSize": {"numberOfStudies": 32, "numberOfParticipants": 67956}, "attributeEstimate": [{"type": {"text": "CI95"}, "range": {"low": {"value": -0.015}, "high": {"value": -0.001}}}]}, {"description": "OR 0.92 (CI95 0.85 to 0.99)", "statisticType": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/statistic-type", "version": "5.0.0-cibuild", "code": "C16932", "display": "Odds Ratio"}]}, "quantity": {"value": 0.92}, "sampleSize": {"numberOfStudies": 32, "numberOfParticipants": 67956}, "attributeEstimate": [{"type": {"text": "CI95"}, "range": {"low": {"value": 0.85}, "high": {"value": 0.99}}}]}], "certainty": [{"description": "Due to serious imprecision", "type": {"coding": [{"system": "http://hl7.org/fhir/certainty-type", "code": "Overall", "display": "Overall certainty"}]}, "rating": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/27834", "code": "RJCS-2004", "display": "Moderate certainty"}]}, "subcomponent": [{"type": {"text": "Risk of Bias"}, "rating": {"text": "NOTSET"}}, {"type": {"text": "Inconsistency"}, "rating": {"text": "NOTSET"}}, {"type": {"text": "Indirectness"}, "rating": {"text": "NOTSET"}}, {"type": {"text": "Imprecision"}, "rating": {"text": "NOTSET"}}, {"type": {"text": "Publication Bias"}, "rating": {"text": "NOTSET"}}]}], "assertion": "GLP-1 receptor agonists probably reduce the risk of nonfatal myocardial infarction compared with standard care.", "url": "https://fevir.net/resources/Evidence/236546", "id": "236546", "publisher": "Computable Publishing LLC", "copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/", "contact": [{"telecom": [{"system": "email", "value": "support@computablepublishing.com"}]}], "extension": [{"extension": [{"url": "type", "valueCode": "part-of"}, {"url": "targetReference", "valueReference": {"type": "Composition", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-conversion-report", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes"}}], "url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/relates-to"}], "description": "This Evidence Resource is referenced in an example for the EBMonFHIR Implementation Guide."}